The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms
Open accessAbstract
Huntington disease (HD) is an inherited neurological disorder caused by a polyglutamine expansion in the protein huntingtin and is characterized by selective neurodegeneration that preferentially occurs in striatal medium spiny neurons. Because the medium spiny neurons are innervated abundantly by glutamatergic axons from cortical neurons, the preferential degeneration in the striatal neurons supports the glutamate excitotoxicity theory for HD pathogenesis. Thus, glutamate uptake by glia may be particularly important for preventing glutamate excitotoxicity in HD. Although mutant huntingtin is expressed ubiquitously in various types of cells, it accumulates and forms aggregates in fewer glial cells than in neuronal cells. It remains largely unknown whether and how mutant huntingtin in glia can contribute to the neurological symptoms of HD. We generated transgenic mice that express N-terminal mutant huntingtin in astrocytes, a major type of glial cell that remove extracellular glutamate in the brain. Although transgenic mutant huntingtin in astrocytes is expressed below the endogenous level, it can cause age-dependent neurological phenotypes in transgenic mice. Mice expressing mutant huntingtin show body weight loss, have motor function deficits, and die earlier than wild-type or control transgenic mice. We also found that mutant huntingtin in astrocytes decreases the expression of glutamate transporter by increasing its binding to Sp1 and reducing the association of Sp1 with the promoter of glutamate transporter. These results imply an important role for glial mutant huntingtin in HD pathology and suggest possibilities for treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,181
G. Vonsattel, J. P., & DiFiglia, M. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199805000-00001 · Cited by 1,306
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., Takahashi, R., Misawa, H., & Cleveland, D. W. (2008) · Nature Neuroscience · doi:10.1038/nn2047 · Cited by 1,140 · cited 4×
“This is consistent with the finding that the GFAP promoter drives the expression of transgenes in astrocytes in the spinal cord of adult mice (18).”
BackgroundResultInfluentialMechanisms of Disease: astrocytes in neurodegenerative disease
Maragakis, N. J., & Rothstein, J. D. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0355 · Cited by 812
Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model
Di Giorgio, F. P., Carrasco, M. A., Siao, M. C., Maniatis, T., & Eggan, K. (2007) · Nature Neuroscience · doi:10.1038/nn1885 · Cited by 799 · cited 5×
“Nagai M, et al. (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons.”
BackgroundInfluentialSchilling, G. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.397 · Cited by 753
Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., Hayden, M. R., & Raymond, L. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00615-3 · Cited by 595
GFAP promoter directs astrocyte-specific expression in transgenic mice
Brenner, M., Kisseberth, W., Su, Y., Besnard, F., & Messing, A. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-03-01030.1994 · Cited by 485
Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity
Shin, J.-Y., Fang, Z.-H., Yu, Z.-X., Wang, C.-E., Li, S.-H., & Li, X.-J. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200508072 · Cited by 477
Self-citationGlial cells as intrinsic components of non-cell-autonomous neurodegenerative disease
Lobsiger, C. S., & Cleveland, D. W. (2007) · Nature Neuroscience · doi:10.1038/nn1988 · Cited by 441
Glutamate Transporters in Neurologic Disease
Maragakis, N. J., & Rothstein, J. D. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.365 · Cited by 324
Behrens, P. F. (2002) · Brain · doi:10.1093/brain/awf180 · Cited by 320
Impaired Glutamate Uptake in the R6 Huntington's Disease Transgenic Mice
Liévens, J.-C., Woodman, B., Mahal, A., Spasic-Boscovic, O., Samuel, D., Kerkerian-Le Goff, L., & Bates, G. P. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0430 · Cited by 313
The Influence of Huntingtin Protein Size on Nuclear Localization and Cellular Toxicity
Hackam, A. S., Singaraja, R., Wellington, C. L., Metzler, M., McCutcheon, K., Zhang, T., Kalchman, M., & Hayden, M. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.5.1097 · Cited by 313
Miller, B. R., Dorner, J. L., Shou, M., Sari, Y., Barton, S. J., Sengelaub, D. R., Kennedy, R. T., & Rebec, G. V. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.004 · Cited by 280 · cited 1×
“have recently shown that up-regulation of GLT-1 transporter attenuates some of the behavioral alterations in the R6/2 transgenic model (35), and recent findings reveal that decortication of glutamatergic projections to the striatum significantly lowered striatal glutamate levels and reduced behavioral phenotypes of R6…”
BackgroundNMDA receptor function in mouse models of Huntington disease
Cepeda, C., Ariano, M. A., Calvert, C. R., Flores‐Hernández, J., Chandler, S. H., Leavitt, B. R., Hayden, M. R., & Levine, M. S. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1244 · Cited by 274
Mutant Huntingtin Causes Context-Dependent Neurodegeneration in Mice with Huntington's Disease
Yu, Z.-X., Li, S.-H., Evans, J., Pillarisetti, A., Li, H., & Li, X.-J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02193.2003 · Cited by 262
Self-citationCuster, S. K., Garden, G. A., Gill, N., Rueb, U., Libby, R. T., Schultz, C., Guyenet, S. J., Deller, T., Westrum, L. E., Sopher, B. L., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1750 · Cited by 240
ARZBERGER, T., KRAMPFL, K., LEIMGRUBER, S., & WEINDL, A. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199704000-00013 · Cited by 232
GFAP-positive progenitor cells produce neurons and oligodendrocytes throughout the CNS
Casper, K. B., & McCarthy, K. D. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.12.006 · Cited by 226
Gu, X., Li, C., Wei, W., Lo, V., Gong, S., Li, S.-H., Iwasato, T., Itohara, S., Li, X.-J., Mody, I., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.03.025 · Cited by 221
Self-citationSu, Z.-Z., Leszczyniecka, M., Kang, D.-C., Sarkar, D., Chao, W., Volsky, D. J., & Fisher, P. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0136555100 · Cited by 199
Tydlacka, S., Wang, C.-E., Wang, X., Li, S., & Li, X.-J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4393-08.2008 · Cited by 184
Self-citationChoi, S. H., Veeraraghavalu, K., Lazarov, O., Marler, S., Ransohoff, R. M., Ramirez, J. M., & Sisodia, S. S. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.033 · Cited by 170
Wang, C.-E., Tydlacka, S., Orr, A. L., Yang, S.-H., Graham, R. K., Hayden, M. R., Li, S., Chan, A. W. S., & Li, X.-J. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn175 · Cited by 163
Self-citationGlutamate Uptake is Reduced in Prefrontal Cortex in Huntington’s Disease
Hassel, B., Tessler, S., Faull, R. L. M., & Emson, P. C. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9463-1 · Cited by 132
Calabresi, P., Centonze, D., Pisani, A., Sancesario, G., Gubellini, P., Marfia, G. A., & Bernardi, G. (1998) · Annals of Neurology · doi:10.1002/ana.410430506 · Cited by 131
Multiple pathways contribute to the pathogenesis of Huntington disease.
Li, S., & Li, X. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-19 · Cited by 121
Self-citationChou, S., Weng, J.-Y., Lai, H., Liao, F., Sun, S. H., Tu, P., Dickson, D. W., & Chern, Y. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0116-08.2008 · Cited by 121
Liévens, J.-C., Rival, T., Iché-Torres, M., Chneiweiss, H., & Birman, S. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi067 · Cited by 102
Brenner, M., & Messing, A. (1996) · Methods · doi:10.1006/meth.1996.0113 · Cited by 90
Neuroprotective Effects of Synaptic Modulation in Huntington's Disease R6/2 Mice
Stack, E. C., Dedeoglu, A., Smith, K. M., Cormier, K., Kubilus, J. K., Bogdanov, M. B., Matson, W. R., Yang, L., Jenkins, B. G., Luthi‐Carter, R., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4318-07.2007 · Cited by 85
Singhrao, S., Thomas, P., Wood, J. D., Macmillan, J., Neal, J. W., Harper, P. S., & Jones, A. L. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6778 · Cited by 81
Huntington's disease, energy, and excitotoxicity
Beal, M. F. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90132-5 · Cited by 67
Hebb, M. O., Denovan‐Wright, E. M., & Robertson, H. A. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9.1099 · Cited by 40
Context-dependent Dysregulation of Transcription by Mutant Huntingtin
Cornett, J. C., Smith, L. M., Friedman, M. J., Shin, J., Li, X., & Li, S.-H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607839200 · Cited by 26
Self-citation
Cited by
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Diversity of astrocyte functions and phenotypes in neural circuits
Khakh, B. S., & Sofroniew, M. V. (2015) · Nature Neuroscience · doi:10.1038/nn.4043 · Cited by 1,239
The blood-brain barrier in aging and neurodegeneration
Knox, E. G., Aburto, M. R., Clarke, G., Cryan, J. F., & O’Driscoll, C. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01511-z · Cited by 738
Astrocytes and disease: a neurodevelopmental perspective
Molofsky, A. V., Krenick, R., Ullian, E., Tsai, H.-H., Deneen, B., Richardson, W. D., Barres, B. A., & Rowitch, D. H. (2012) · Genes & Development · doi:10.1101/gad.188326.112 · Cited by 682
Function and therapeutic value of astrocytes in neurological diseases
Lee, H.-G., Wheeler, M. A., & Quintana, F. J. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00390-x · Cited by 662
Metadata
- Authors
- Bradford, J., Shin, J.-Y., Roberts, M., Wang, C.-E., Li, X.-J., & Li, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-12-29
- Volume
- 106
- Issue
- 52
- Pages
- 22480-22485
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2039436205
- Cited by
- 362
- References
- 37
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.